» Articles » PMID: 32507880

Evaluation of Crohn's Disease Activity: Development of an Ultrasound Score in a Multicenter Study

Overview
Specialty Gastroenterology
Date 2020 Jun 9
PMID 32507880
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Our goal in this multicentric prospective study was 2-fold: first, to test the diagnostic accuracy of ultrasound, color Doppler imaging (CDI), and contrast-enhanced ultrasound (CEUS) in identifying disease activity in patients with Crohn's disease (CD) compared with endoscopy as the reference standard; and, second, to construct a sonographic score that allows disease activity to be detected.

Materials And Methods: Seventy-two patients with CD from 3 hospitals underwent within a 30-day period both colonoscopy and ultrasound (US), including mural thickness, CDI, and CEUS, prospectively as part of clinical care. A multivariate analysis was carried out to assess the influence of each of the ultrasound variables in predicting endoscopic activity. We then developed a predictive ultrasound score for disease activity, and a receiver operating characteristic (ROC) curve was constructed to determine the area under the ROC curve (AUC) and the best cut-off score value to discriminate between active and inactive disease.

Results: Sonographic findings that were independent predictors of the presence of active disease at endoscopy were wall thickness, color grade, and contrast parameters. A score based on those variables showed high accuracy in predicting active disease, with an area under the ROC curve of 0.972. A simpler index, without contrast parameters, also showed high accuracy in detecting disease activity (AUC, 0.923).

Conclusion: A score based on wall thickness, color Doppler grade, and contrast parameters showed high accuracy in predicting active disease. A score without including the use of contrast agent had practically similar results and is easier to use in monitoring response to treatment.

Citing Articles

The role of intestinal ultrasound with colour Doppler in predicting the response to biologic therapy in inflammatory bowel disease patients.

El-Nady M, El-Hefny N, Fathy H, Ali W, Ashmawy A Prz Gastroenterol. 2025; 16(4):416-422.

PMID: 39810868 PMC: 11726221. DOI: 10.5114/pg.2023.132932.


Validation of intestinal ultrasound scores in assessing endoscopic activity of colonic and small intestinal Crohn's disease in a southwest Chinese cohort: a retrospective cross-sectional study.

Zhao J, Ju J, Luo Y, Zhuang H Quant Imaging Med Surg. 2024; 14(12):8374-8386.

PMID: 39698692 PMC: 11652024. DOI: 10.21037/qims-24-742.


Novelties and Perspectives of Intestinal Ultrasound in the Personalised Management of Patients with Inflammatory Bowel Diseases-A Systematic Review.

Mihai V, Gheorghe L, Rezus I, Jucan A, Andronic M, Gavrilescu O Diagnostics (Basel). 2024; 14(8).

PMID: 38667458 PMC: 11049436. DOI: 10.3390/diagnostics14080812.


Magnetic Resonance Enterography and Intestinal Ultrasound for the Assessment and Monitoring of Crohn's Disease.

Kumar S, De Kock I, Blad W, Hare R, Pollok R, Taylor S J Crohns Colitis. 2024; 18(9):1450-1463.

PMID: 38554104 PMC: 11369078. DOI: 10.1093/ecco-jcc/jjae042.


Diagnostic accuracy of bowel ultrasonography in patients with inflammatory bowel disease: a systematic review and meta-analysis.

Malik S, Venugopalan S, Tenorio B, Khan S, Loganathan P, Navaneethan U Ann Gastroenterol. 2024; 37(1):54-63.

PMID: 38223248 PMC: 10785028. DOI: 10.20524/aog.2024.0842.